| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 32.56% | 1.62% | -2.24% | 105/140 | 52.37% | 健帆生物 | 78.46% | 行业排名> |
| 2025-12-31 | 33.31% | 0.48% | -0.74% | 103/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 33.56% | 0.13% | 0.55% | 102/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 33.37% | -0.59% | 4.15% | 106/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 32.04% | 1.45% | -3.34% | 105/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 33.15% | 13.23% | -1.08% | 108/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 33.51% | 18.8% | -0.18% | 106/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 33.57% | 24.71% | 6.28% | 109/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 31.59% | 33.57% | 7.89% | 105/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 29.28% | 9.06% | 3.78% | 114/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 28.21% | -0.89% | 4.79% | 109/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 26.92% | -8.16% | 13.84% | 114/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 23.65% | -19.05% | -11.9% | 111/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 26.84% | -9.36% | -5.69% | 115/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 28.46% | -4.12% | -2.89% | 107/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 29.31% | -3.56% | 0.34% | 111/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 29.21% | 6.02% | -1.36% | 101/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 29.62% | -11.74% | -0.23% | 116/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 29.69% | -22.33% | -2.33% | 100/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 30.39% | -18.83% | 10.31% | 108/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 27.55% | -22.53% | -17.89% | 91/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 33.56% | -9.08% | -12.21% | 115/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-09-30 | 38.22% | 3.06% | 2.08% | 78/140 | 62.21% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 37.44% | -0.4% | 5.28% | 95/140 | 60.36% | 正海生物 | 92.69% | 行业排名> |
| 2020-03-31 | 35.57% | -5.08% | -3.63% | 64/140 | 58.8% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 36.91% | 2.55% | -0.49% | 97/140 | 56.96% | 正海生物 | 94.38% | 行业排名> |
| 2019-09-30 | 37.09% | 5.17% | -1.35% | 51/140 | 55.83% | 正海生物 | 93.12% | 行业排名> |
| 2019-06-30 | 37.6% | 9.7% | 0.34% | 59/140 | 57.93% | 正海生物 | 93.78% | 行业排名> |
| 2019-03-31 | 37.47% | 18.17% | 4.12% | 42/140 | 52.61% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 35.99% | 11.69% | 2.06% | 88/140 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2018-09-30 | 35.26% | 9% | 2.9% | 39/140 | 52.76% | 正海生物 | 93.08% | 行业排名> |
| 2018-06-30 | 34.27% | 11.44% | 8.08% | 47/140 | 53.06% | 正海生物 | 92.83% | 行业排名> |
| 2018-03-31 | 31.71% | 11.59% | -1.59% | 43/140 | 52.55% | 正海生物 | 92.44% | 行业排名> |
| 2017-12-31 | 32.22% | -1.78% | -0.41% | 89/140 | 56.1% | 正海生物 | 92.7% | 行业排名> |
| 2017-09-30 | 32.35% | -1.78% | 5.2% | 39/140 | 53.53% | 正海生物 | 93.67% | 行业排名> |
| 2017-06-30 | 30.75% | -7.2% | 8.23% | 52/140 | 54.85% | 正海生物 | 94.14% | 行业排名> |
| 2017-03-31 | 28.41% | -10.27% | -13.39% | 41/140 | 54.29% | 正海生物 | 93.83% | 行业排名> |
| 2016-12-31 | 32.81% | 4.79% | -0.4% | 70/140 | 57.35% | 正海生物 | 93.69% | 行业排名> |
| 2016-09-30 | 32.94% | 7.29% | -0.6% | 34/140 | 51.85% | 正海生物 | 92.79% | 行业排名> |
| 2016-06-30 | 33.14% | 10.23% | 4.65% | 42/140 | 52.6% | 健帆生物 | 84.23% | 行业排名> |
| 2016-03-31 | 31.66% | 6.58% | 1.14% | 31/140 | 50.24% | *ST明德 | 86.71% | 行业排名> |

微信公众号
证券之星APP


